Table 2.

CCL20 expression and clinicopathological features in LUAD.

Variables	n	CCL20 expression		p-value*
		Low expression	High expression
Gender				0.81
Male	46	17	29
Female	34	14	20
Age				0.17
≥ 55	43	14	29
< 55	37	18	19
T				0.97
T0	2	1	1
T1	18	6	12
T2	44	18	26
T3	10	4	6
T4	6	2	4
N				0.01
N0	29	16	13
N1 + N4	51	13	38
Stage				0.02
I	33	15	18
III + IV	46	11	37

Correlation of CCL20 expression and clinicopathological features in 80 patients with Lung Adenocarcinoma. TNM stage information was missing one patient.